Notice of Intent: Chromium GEM-X sequencing reagents

The NIH’s National Institute of Neurological Disorders and Stroke (NINDS) plans to purchase Chromium GEM‑X single‑cell RNA‑sequencing reagents from 10X Genomics for a Gulf War Illness (GWI) research study. The acquisition will be a firm‑fixed‑price purchase order; the government is not soliciting competitive quotes but invites small‑business vendors to submit capability statements demonstrating their ability to fulfill the requirement. The award is expected within ten days of the notice, and responses must be emailed by 3:00 p.m. EDT on September 10, 2026. • Primary need: Chromium GEM‑X library preparation kits for single‑cell RNA, T‑cell receptor, and B‑cell receptor sequencing. • Intended use: Generate gene‑expression, TCR, and BCR libraries for GWI patient samples, supporting downstream sequencing and data analysis. • Procurement method: Sole‑source firm‑fixed‑price purchase order to 10X Genomics; small‑business capability statements accepted for potential competition. • Submission: Email capability statement to David Shen (NIH) by Sep 10, 2026. • NAICS listed: 325414 (Biological Product Manufacturing).